These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 869984)

  • 1. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
    Hill SA; Fowler JF
    Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
    Sheldon PW; Hill SA
    Br J Cancer; 1977 Jun; 35(6):795-808. PubMed ID: 871367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
    Sheldon PW; Hill SA
    Br J Cancer; 1977 Aug; 36(2):198-205. PubMed ID: 911657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
    Brown JM
    Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159.
    Peters LJ
    Br J Radiol; 1976 Aug; 49(584):708-15. PubMed ID: 953390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
    Brown JM
    Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
    [No Abstract]   [Full Text] [Related]  

  • 7. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
    Denekamp J; Harris SR
    Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
    Sheldon PW; Foster JL; Fowler JF
    Br J Cancer; 1974 Dec; 30(6):560-5. PubMed ID: 4451633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
    Fowler JF; Sheldon PW; Denekamp J; Field SB
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
    Sheldon PW; Hill SA; Foster JL; Fowler JF
    Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
    Bleehen NM; Honess DJ; Morgan JE
    Br J Cancer; 1977 Mar; 35(3):299-306. PubMed ID: 856237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of the solid Guerin epitheliomas of rats to fractionated irradiation and a new 4-nitroimidazole.
    Watras J; Wideł M; Suwiński J
    Br J Cancer; 1979 Sep; 40(3):354-9. PubMed ID: 508563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
    Guichard M; Malaise EP
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
    Rofstad EK; Brustad T
    Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
    Tada T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
    Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
    Dische S
    Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
    Thomlinson RH; Dische S; Gray AJ; Errington LM
    Clin Radiol; 1976 Apr; 27(2):167-74. PubMed ID: 776494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization by SR-2508 plus Ro 03-8799.
    Stone HB; Luu YH; Lam KN
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.